Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
14,181,041
-
Shares change
-
+9,031,213
-
Total reported value, excl. options
-
$2,246,741,087
-
Value change
-
+$1,432,250,063
-
Put/Call ratio
-
59%
-
Number of buys
-
129
-
Number of sells
-
43
-
Price
-
$158.49
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q3 2018
211 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of 30 Sep 2018.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) had 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,181,041 shares of stock of the company.
Largest 10 holders included FIRST TRUST ADVISORS LP, CHURCHILL MANAGEMENT Corp, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, RAYMOND JAMES & ASSOCIATES, Raymond James Financial Services Advisors, Inc., ROYAL BANK OF CANADA, and AMERIPRISE FINANCIAL INC.
This table shows the top 187 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.